We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Zocor Offer Draws Predatory Pricing Accusations

Law360 (June 22, 2006, 12:00 AM EDT) -- With a generic version of cholesterol drug Zocor hitting shelves today, an offer by Merck & Co. to provide the drug for below the generic price has some accusing the pharmaceutical company of predatory pricing.

Merck offered to sell the brand-name drug to insurance providers at a lower price than Teva Pharmaceuticals, which won the rights to a 180-day period of market exclusivity for a generic version of Zocor.

The insurance provider would in turn offer the drug to patients for the co-payment fee normally charged...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.